Biopharmaceutical Company Seeking Seed Funding for Skin Cancer Drug Development

This listing represents a seed funding round for a biopharmaceutical company specializing in the development of novel treatments for precancerous skin conditions, skin cancer, and inflammatory skin diseases. The company is seeking $2.5 million USD to fund its Phase I clinical trial for a promising topical drug candidate. This milestone is anticipated to be a significant value inflection point, with potential for substantial investor returns mirroring the success of comparable companies that have seen 8-10x valuation gains within 2-3 years. The company plans to utilize SAFE agreements for this funding round and is not seeking loans. The company is located in Vancouver, BC.